IVF 8-K 2026-11-04

INVO Fertility, Inc. (IVF) 8-K dated 2026-11-04 — accession 0001493152-26-049991.

INVO Fertility, Inc. (IVF) is a medical devices company listed on US.

INVO Fertility, Inc. filed a 8-K on 2026-11-04. Accession 0001493152-26-049991.

This 8-K covers: Bylaws or fiscal year change (Item 5.03), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IVF revenue for 2025-12-31 was $6.8M. Net income was -$23.3M. Revenue was up 4.7% from 2024-12-31 to 2025-12-31. IVF currently screens at market cap $2.8M.

Not investment advice. The IVF SEC hub lists recent forms. The stock page is the research view.